Independent fund research. Built on SEC filings.

How we research funds

ETF · Technology Sector · Global X

GNOM Holdings: What Global X Genomics & Biotechnology ETF Owns

Ticker GNOM · Since 2019-04-05 · · Holdings as of May 31, 2026

Expense ratio
0.5%$50/yr per $10k
5-yr return
−13.3%annualized
1-yr return
+19.0%as of Dec 2025
Net assets
$55.8Mall share classes
Holdings
51

Bottom line

What does GNOM hold?

GNOM held 51 positions as of May 31, 2026. Its largest holding is Guardant Health, Inc. at 5.59% of the fund, and the top 10 positions add up to 42.5%. By asset type it is 100% stocks, 3% repurchase agreements.

Updated Jul 29, 2026

GNOM top 25 holdings

#HoldingType% of fundValue
1 Guardant Health, Inc.
GUARDANT HEALTH INC COMMON STOCK
Stocks 5.59%$3.1M
2 Illumina, Inc.
ILLUMINA INC COMMON STOCK
Stocks 4.82%$2.7M
3 Natera, Inc.
NATERA INC COMMON STOCK
Stocks 4.15%$2.3M
4 Biomarin Pharmaceutical Inc.
BIOMARIN PHARMACEUTICAL INC COMMON STOCK
Stocks 4.09%$2.3M
5 Arrowhead Pharmaceuticals, Inc.
ARROWHEAD PHARMACEUTICALS IN COMMON STOCK
Stocks 4.07%$2.3M
6 Legend Biotech Corp
LEGEND BIOTECH CORP-ADR DEPOSITARY RECEIPT
Stocks 4.05%$2.3M
7 Praxis Precision Medicines Inc
PRAXIS PRECISION MEDICINES I COMMON STOCK
Stocks 4.01%$2.2M
8 Twist Bioscience Corp
TWIST BIOSCIENCE CORP COMMON STOCK
Stocks 3.97%$2.2M
9 Vertex Pharmaceuticals Incorporated
VERTEX PHARMACEUTICALS INC COMMON STOCK
Stocks 3.95%$2.2M
10 CRISPR Therapeutics AG
CRISPR THERAPEUTICS AG COMMON STOCK
Stocks 3.85%$2.1M
11 Veracyte Inc
VERACYTE INC COMMON STOCK
Stocks 3.64%$2.0M
12 Qiagen N.V.
QIAGEN N.V. COMMON STOCK
Stocks 3.54%$2.0M
13 BioNTech SE
BIONTECH SE-ADR DEPOSITARY RECEIPT
Stocks 3.41%$1.9M
14 Bio-techne Corporation
BIO-TECHNE CORP COMMON STOCK
Stocks 3.41%$1.9M
15 Moderna, Inc.
MODERNA INC COMMON STOCK
Stocks 3.28%$1.8M
16 10X Genomics Inc
10X GENOMICS INC-CLASS A COMMON STOCK
Stocks 3.23%$1.8M
17 Beam Therapeutics Inc
BEAM THERAPEUTICS INC COMMON STOCK
Stocks 3.09%$1.7M
18 Bnyrepos Repurchase agreements 3.05%$1.7M
19 Eli Lilly And Company
ELI LILLY & CO COMMON STOCK
Stocks 2.32%$1.3M
20 Ultragenyx Pharmaceutical Inc
ULTRAGENYX PHARMACEUTICAL IN COMMON STOCK
Stocks 2.25%$1.3M
21 Caris Life Sciences, Inc.
CARIS LIFE SCIENCES INC COMMON STOCK
Stocks 2.03%$1.1M
22 Genscript Biotech Corp
GENSCRIPT BIOTECH CORP COMMON STOCK
Stocks 2.00%$1.1M
23 BillionToOne Inc
BILLIONTOONE INC CL A COMMON STOCK
Stocks 1.97%$1.1M
24 Gilead Sciences, Inc.
GILEAD SCIENCES INC COMMON STOCK
Stocks 1.95%$1.1M
25 Astrazeneca Plc
ASTRAZENECA PLC COMMON STOCK
Stocks 1.83%$1.0M

Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 29, 2026

Asset mix

Stocks99.9%
Repurchase agreements3.1%

Country exposure

GB1.8%
HK2.0%
US99.1%